SymphonyAI
VC Fund
Los Altos, United States
SymphonyAI is an enterprise AI company that provides leading AI-centric solutions for transforming the enterprise by driving revenue growth and operational excellence for retail, CPG, healthcare, life sciences, industrial manufacturing, financial, media and entertainment verticals, the public sector, and for IT and other key enterprise horizontalfunctions. The group’s current portfolio is made up of: retail and CPG (Symphony RetailAI), life sciences (ConcertAI), healthcare (TeraRecon), media and entertainment (Symphony MediaAI), industrial manufacturing (Symphony IndustrialAI), financial services (Symphony AyasdiAI), public sector (Symphony Government Solutions) and IT (Symphony SummitAI). Founded by Dr. Romesh Wadhwani, SymphonyAI is one of the fastest-growing companies in the business-to-business AI solutions sector with more than 2,200 employees.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries SymphonyAI invests in
Stages SymphonyAI invests in
Countries SymphonyAI invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jennifer Trzepacz
|
|||
Ishan Manaktala
|
|||
Mark Tice
|
|||
Pradyut Shah
|
|||
Investment Focus
Industry
- Health Care 2 (33%)
- Biotechnology 2 (33%)
- Artificial Intelligence 2 (33%)
- SaaS 1 (17%)
- Medical 1 (17%)
Stage
- Series A 1 (17%)
- Series B 1 (17%)
- Venture - Series Unknown 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jennifer Trzepacz
Chief People Officer
|
Chief People Officer | Total investments: 0 | Find email | |
|
Ishan Manaktala
Operating Partner
|
Operating Partner | Total investments: 0 | Find email | |
|
Mark Tice
Operating Partner
|
Operating Partner | Total investments: 0 | Find email | |
|
Pradyut Shah
Partner
|
Partner | Total investments: 0 | Find email | |
Romesh Wadhwani
Chairman and CEO
|
Chairman and CEO | Total investments: 4 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ansel Health
|
Ansel Health is a developer of a health insurance platform intended for employers to enhance their employee benefits with a simple supplemental health benefits plan. | $20M / Venture - Series Unknown / Jan 23, 2024 | |
|
Ansel Health
|
Ansel Health is a developer of a health insurance platform intended for employers to enhance their employee benefits with a simple supplemental health benefits plan. | $15M / Series A / Apr 22, 2021 | |
|
Ansel Health
|
Ansel Health is a developer of a health insurance platform intended for employers to enhance their employee benefits with a simple supplemental health benefits plan. | $1.5M / Seed / Aug 10, 2020 | |
|
Ansel Health
|
Ansel Health is a developer of a health insurance platform intended for employers to enhance their employee benefits with a simple supplemental health benefits plan. | $5.5M / Seed / May 21, 2020 | |
ConcertAI
|
ConcertAI is a developer of medical research tool suite intended to design and deliver care-based oncology research and data analytics. It is an integrated real-world data and AI-driven solutions to transform how insights are generated and accelerate therapeutic innovations to patients.It was incorporated in 2018 and is based in Boston,Massachusetts. | $150M / Series B / Jan 13, 2020 | |
Precision Health AI
|
Precision Health AI is a platform technology company focused on applications of AI to Oncology. Serving Pharma, Life Sciences, Providers, and Payers PH.AI combines modern AI technology with best in class oncology data with a focus on improving outcomes and driving value based care. | $20M / Series A / Sep 20, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does SymphonyAI invest in?
SymphonyAI invests primarily in Health Care, Biotechnology and Artificial Intelligence startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact SymphonyAI?
Public channels for SymphonyAI include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SymphonyAI?
The team at SymphonyAI includes Jennifer Trzepacz (Chief People Officer), Ishan Manaktala (Operating Partner) and Mark Tice (Operating Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
